(Q38206640)

31 August 2017

title

Microalbuminuria: target for renoprotective therapy PRO. (English)

1 reference

31 August 2017

Sara S Roscioni

1

1 reference

31 August 2017

Hiddo J Lambers Heerspink

series ordinal

2

1 reference

31 August 2017

Dick de Zeeuw

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

23 April 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

86

1 reference

31 August 2017

issue

1

1 reference

31 August 2017

page(s)

40-49

1 reference

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Introduction to surrogate markers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Update on microalbuminuria as a biomarker in renal and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Comparison of different measures of urinary protein excretion for prediction of renal events

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

First morning voids are more reliable than spot urine samples to assess microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Screening for albuminuria identifies individuals at increased renal risk

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Proteinuria and the risk of developing end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Properties of the glomerular barrier and mechanisms of proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The cellular basis of albuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Pathogenesis and progression of proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Hereditary proteinuria syndromes and mechanisms of proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

High glucose causes dysfunction of the human glomerular endothelial glycocalyx

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Increased Transcapillary Escape Rate of Albumin in Microalbuminuric Type II Diabetic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

How does proteinuria cause progressive renal damage?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Renal albumin absorption in physiology and pathology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Renal tubule albumin transport

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albumin induces NF-kappaB expression in human proximal tubule-derived cells (IHKE-1).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albumin activates ERK via EGF receptor in human renal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albumin stimulates the accumulation of extracellular matrix in renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

PKB/Akt partners with Dab2 in albumin endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Albumin transport and processing by the proximal tubule: physiology and pathophysiology.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Urinary excretion of glycated albumin in insulin-dependent diabetic patients with normal urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Pathophysiology of Progressive Nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Cubilin is essential for albumin reabsorption in the renal proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Cubilin is an albumin binding protein important for renal tubular albumin reabsorption

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The role of proteinuria in the progression of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Paracrine stimulation of human renal fibroblasts by proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Bardoxolone methyl decreases megalin and activates nrf2 in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Proteinuria as a surrogate end point--more data are needed

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.490

7 January 2021

Identifiers

DOI

10.1038/KI.2013.490

1 reference

Dimensions Publication ID

31 August 2017

1006378486

0 references

1 reference